Mucolytiques et mucorégulateurs que sait-on?

Lenoir, 1988, La mucoviscidose Ziment, 1978, Respiratory pharmacology and therapeutics, 41 Weiss, 1981, Mukoziliare clearance unter sekretolytischer beeinflussung durch ambroxol, Prax. Pneumol., 343-386 Weiss, 1981, Effect of a beta-adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with cold, Chest, 80, 881, 10.1378/chest.80.6.881 Grassi, 1983, Biomedical and functional changes in bronchoalveolar parameters induced by ambroxol treatment of chronic bronchitis, 361 Bertoli, 1983, Action of ambroxol on mucociliary clearance, 349 Morgenroth, 1975, Unspezifische Begleitreaktion in der Bronchialwand bei der Lungentuberkulose und ihre Behandlung mi NA 872, Wien Med. Wschr., 125, 34 Catena, 1983, The components of alveolar surfactant of the human lung in normal and in pathological states, 33 Curti, 1983, Clinical study of the effect of ambroxol on lung-function tests in cigarette smokers without other pulmonary disease, Ospedale generale Sondalo—Italie Heissler, 1976, Sputumviskositaet und Sputumviskosimetrie. Teill III. Sputumviskosimetrie bei Bronchosekretolytika, Wien. Med. Wschr., 126, 13 Allegra, 1983, Rheology of bronchial fluide assessed by oscillations, 319 Polu, 1984, Les fluidifiants bronchiques: pharmacologie des mucomodificateurs bronchiques, Sem. Hôp. Paris, 9, 643 Perini, 1985, La mucoviscidose: orientations actuelles de la recherche, Bull. Eur. Physiopath. respir., 21, 569 Expector — L'opération mucokinésie Ambroxol — Laboratoire Boehringer Ingelheim. 1990, Rev. Int. Pédiatr. Chiara, 1983, The prevention of post-operative ARDS. Double blind clinical testing about the effects of ambroxol on pulmonary gas exchanage, Urg. Chir. Comment, 6, 1 Chiara, 1983, The prevention of post-operative ARDS. Double blind clinical testing about the effects of ambroxol on pulmonary gas exchanage, Urg. Chir. Comment, 6, 1 Wiemeyer, 1981, Influence of ambroxol on the bronchopulmonary level of antibiotics, Arzneim. Forsch./Drug. Res., 31, 6 Wiemeyer, 1981, Influence of ambroxol on the bronchopulmonary level of antibiotics, Arzneim. Forsch./Drug. Res., 31, 974 Berthelot G., Pierre J., Bergogne-Berezin E. — Antibiotiques et fluidifiants bronchiques. — Documentation des Laboratoires Boehringer Ingelheim (en cours de publication). Spatola, 1987, Influence of ambroxol on lung tissue penetration of amoxicillin, Arzneim. Forsch./Drug. res., 37 Gene, 1987, Influence of ambroxol on amoxicillin levels in bronchoalveolar lavage fluid, Arzneim. Forsch./Drug. Res., 37 Maesen, 1983, Does ambroxol influence the intestinal absorption and the penetration of doxycycline into the sputum of patients with chronic bronchitis?, International Symposium on the Surfactant System of the lung, Rome, 2 Bergogne-Berezin, 1978, Pharmacocinétique des antibiotiques dans les voies respiratoires, Nouv. Presse Med., 7, 2831 Berthelot, 1979, Intérêt de l'étude des concentrations d'antibiotiques dans les sécrétions bronchiques «in situ, Rev. Fr. Mal. resp., 7, 597 Wong, 1985, Estude multicentrico com ambroxol ampolas em afeccoes broncopulmonares e na profilaxia de complicacoes pulmonares, Rev. Bras. Med., 42, 206 Weinmann, 1981, Amboxol (Mucosolvan®) in der Paediatrie, Therapiewoche, 31, 7940